Literature DB >> 13680127

Fatty acid metabolism and insulin secretion in pancreatic beta cells.

G C Yaney1, B E Corkey.   

Abstract

Increases in glucose or fatty acids affect metabolism via changes in long-chain acyl-CoA formation and chronically elevated fatty acids increase total cellular CoA. Understanding the response of pancreatic beta cells to increased amounts of fuel and the role that altered insulin secretion plays in the development and maintenance of obesity and Type 2 diabetes is important. Data indicate that the activated form of fatty acids acts as an effector molecule in stimulus-secretion coupling. Glucose increases cytosolic long-chain acyl-CoA because it increases the "switch" compound malonyl-CoA that blocks mitochondrial beta-oxidation, thus implementing a shift from fatty acid to glucose oxidation. We present arguments in support of the following: (i) A source of fatty acid either exogenous or endogenous (derived by lipolysis of triglyceride) is necessary to support normal insulin secretion; (ii) a rapid increase of fatty acids potentiates glucose-stimulated secretion by increasing fatty acyl-CoA or complex lipid concentrations that act distally by modulating key enzymes such as protein kinase C or the exocytotic machinery; (iii) a chronic increase of fatty acids enhances basal secretion by the same mechanism, but promotes obesity and a diminished response to stimulatory glucose; (iv) agents which raise cAMP act as incretins, at least in part, by stimulating lipolysis via beta-cell hormone-sensitive lipase activation. Furthermore, increased triglyceride stores can give higher rates of lipolysis and thus influence both basal and stimulated insulin secretion. These points highlight the important roles of NEFA, LC-CoA, and their esterified derivatives in affecting insulin secretion in both normal and pathological states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680127     DOI: 10.1007/s00125-003-1207-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  181 in total

1.  The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin.

Authors:  T Yoshida
Journal:  Am J Clin Nutr       Date:  1992-01       Impact factor: 7.045

2.  Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion.

Authors:  C Warnotte; M Nenquin; J C Henquin
Journal:  Mol Cell Endocrinol       Date:  1999-07-20       Impact factor: 4.102

3.  Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity.

Authors:  O Larsson; J T Deeney; R Bränström; P O Berggren; B E Corkey
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

Review 4.  Acyl CoA regulation of metabolism and signal transduction.

Authors:  B E Corkey; J T Deeney
Journal:  Prog Clin Biol Res       Date:  1990

5.  Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content.

Authors:  Y Q Liu; K Tornheim; J L Leahy
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

6.  Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release.

Authors:  Y Shimazaki; T Nishiki; A Omori; M Sekiguchi; Y Kamata; S Kozaki; M Takahashi
Journal:  J Biol Chem       Date:  1996-06-14       Impact factor: 5.157

7.  Protein kinase C in beta-cells: expression of multiple isoforms and involvement in cholinergic stimulation of insulin secretion.

Authors:  Y M Tian; V Urquidi; S J Ashcroft
Journal:  Mol Cell Endocrinol       Date:  1996-05-31       Impact factor: 4.102

8.  Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis.

Authors:  M L Vitale; E P Seward; J M Trifaró
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

9.  Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.

Authors:  M M Chou; W Hou; J Johnson; L K Graham; M H Lee; C S Chen; A C Newton; B S Schaffhausen; A Toker
Journal:  Curr Biol       Date:  1998-09-24       Impact factor: 10.834

10.  Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole islets.

Authors:  K L Knutson; M Hoenig
Journal:  Endocrinology       Date:  1994-09       Impact factor: 4.736

View more
  71 in total

Review 1.  Molecular defects in insulin secretion in type-2 diabetes.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins.

Authors:  Keren Bahar Halpern; Anna Veprik; Nir Rubins; Orly Naaman; Michael D Walker
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 3.  The molecular genetics of sulfonylurea receptors in the pathogenesis and treatment of insulin secretory disorders and type 2 diabetes.

Authors:  Veronica Lang; Nermeen Youssef; Peter E Light
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

4.  Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.

Authors:  Ximena Lopez; Aaron Cypess; Raquel Manning; Sheila O'Shea; Rohit N Kulkarni; Allison B Goldfine
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 5.  G protein-coupled receptors as targets for anti-diabetic therapeutics.

Authors:  Da Young Oh; Jerrold M Olefsky
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

6.  Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.

Authors:  Annalisa Natalicchio; Rossella Labarbuta; Federica Tortosa; Giuseppina Biondi; Nicola Marrano; Alessandro Peschechera; Emanuele Carchia; Maura Roberta Orlando; Anna Leonardini; Angelo Cignarelli; Piero Marchetti; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2013-08-31       Impact factor: 10.122

7.  Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Authors:  Sarah-Jane Watson; Alastair J H Brown; Nicholas D Holliday
Journal:  Mol Pharmacol       Date:  2012-01-26       Impact factor: 4.436

Review 8.  Connecting pancreatic islet lipid metabolism with insulin secretion and the development of type 2 diabetes.

Authors:  Yumi Imai; Ryan S Cousins; Siming Liu; Brian M Phelps; Joseph A Promes
Journal:  Ann N Y Acad Sci       Date:  2019-04-02       Impact factor: 5.691

9.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

10.  Analysis of gene expression in pancreatic islets from diet-induced obese mice.

Authors:  Yumi Imai; Hiral R Patel; Nicolai M Doliba; Franz M Matschinsky; John W Tobias; Rexford S Ahima
Journal:  Physiol Genomics       Date:  2008-10-14       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.